In silico assessment of talus osteochondral lesion size and location on biomechanical load distribution using tilted talar dome planes
Acta Orthopaedica et Traumatologica Turcica · 2025
DOI: 10.5152/j.aott.2025.25444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Orthopaedica et Traumatologica Turcica, 2025. Verfasst von Lercan Aslan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Traumatology, Koç University School of Medicine, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Talus, Ankle Joint, Cartilage, Articular. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
This study aimed to computationally evaluate the effects of lesions of varying sizes and locations on stress distribution and ankle stiffness across the nine-zone grid of the talar dome in three different ankle positions.
Methods
An adult ankle geometry was modeled with 1 mm of cartilage on both sides of the tibiotalar contact. Lesions with diameters of 4.5, 6.4, and 9 mm were created on the talar dome at each grid partition, ranging from section 1 (anteromedial) to 9 (posterolateral). Thekey innovation of the study was the use of tilted talar planes to account for the dome’s curvature, enabling more accurate lesion model ing and biomechanical analysis. Percent changes in osteochondral von Mises stress distribution and ankle stiffness parameters were investigated using finite element analysis. Based on the designated design parameters, 81 different cases were modeled and simulated.
Results
Zones 7 (posteromedial, −33.2% change in stiffness for a 9 mm defect), 3 (anterolateral, −24.2% change in stiffness for a 9 mmdefect), and 8 (mid-posterior, −48.8% change in stiffness for a 9 mm defect) were found to be the most critical zones, showing evidence of decreased ankle stiffness in neutral, dorsiflexion, and plantarflexion positions, respectively. Zone 9 (posterolateral; neutral −4.7%, dorsi f lexion 5.4%, plantarflexion 0.17% stiffness change for a 9 mm defect) was found to be the least critical zone in terms of biomechanical stiffness.
Conclusion
From a clinical standpoint, since lesions in zones 8, 7, and 3 significantly impact joint biomechanics compared to other zones, more aggressive cartilage restoration or augmentation could be required while lesions in less problematic zones like zone 9 can be treated withmicrofracture surgery. Cite this article as: Aslan L, Subasi O, Karaismailoglu B, et al. In silico assessment of talus osteochondral lesion size and location on biomechanical load distribution using tilted talar dome planes. Acta Orthop Traumatol Turc., 2025;59(6):361-367.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Orthopaedics and Traumatology, Koç University School of Medicine, İstanbul, Türkiye.
- Foot & Ankle Research and Innovation Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Zitieren
APA
Aslan, L., Subasi, O., Karaismailoglu, B., Gedik, C. C., Yuruk, B., Esfahani, S. A., & Eren, I. (2025). In silico assessment of talus osteochondral lesion size and location on biomechanical load distribution using tilted talar dome planes. Acta Orthopaedica et Traumatologica Turcica. https://doi.org/10.5152/j.aott.2025.25444
Vancouver
Aslan L, Subasi O, Karaismailoglu B, Gedik CC, Yuruk B, Esfahani SA, et al. In silico assessment of talus osteochondral lesion size and location on biomechanical load distribution using tilted talar dome planes. Acta Orthopaedica et Traumatologica Turcica. 2025. doi:10.5152/j.aott.2025.25444
BibTeX
@article{Aslan2025,
author = {Aslan, Lercan and Subasi, Omer and Karaismailoglu, Bedri and Gedik, Cemil Cihad and Yuruk, Batuhan and Esfahani, Soheil-Ashkani and Eren, Ilker},
title = {In silico assessment of talus osteochondral lesion size and location on biomechanical load distribution using tilted talar dome planes},
journal = {Acta Orthopaedica et Traumatologica Turcica},
year = {2025},
doi = {10.5152/j.aott.2025.25444}
}
EUVIMED